At Quinz, we support investors — including venture capital funds, family offices, and strategic angels — throughout the entire investment lifecycle, from early-stage funding to exit. Our Corporate & Finance team provides comprehensive legal guidance on all types of venture capital transactions, both domestic and cross-border.
We assist clients with:
- Investment rounds: from seed to Series A, B and C, we negotiate and draft investment agreements, shareholders’ agreements, convertible instruments (SAFE, notes), and advise on governance and control rights.
- Due diligence and deal execution: we conduct focused legal due diligence reviews — with particular attention to intellectual property, regulatory compliance, and founder/investor dynamics — and manage transactions in a hands-on and efficient manner.
- Post-investment matters: we advise on follow-on funding, board representation, corporate restructuring and other investor-related matters throughout the life of the investment.
- Exit strategies: our team guides clients through secondary sales, trade sales and IPOs, ensuring well-structured and commercially aligned outcomes.
A key strength of Quinz lies in the close collaboration between our Corporate & Finance team and our market-leading Life Sciences team. We have deep experience supporting investments in biotech, medtech and digital health — sectors where legal, regulatory and IP considerations are critical. This integrated approach allows us to provide sector-savvy, transaction-focused advice that aligns with the commercial and strategic needs of both investors and target companies.
We are known for our pragmatic, responsive and business-minded approach — helping clients close deals swiftly while managing risk effectively.
